[MYGN] YoY Quarter Result on 30-Jun-2019 [#Q2]

Stock
[MYGN] Myriad Genetics, Inc.
Announcement Date
13-Aug-2019
Financial Year
2019
Quarter
30-Jun-2019 [#Q2]
Profit Trend
QoQ- -160.87%
YoY- -132.06%
Quarter Report
MYGN's Result
MYGN's Financial Summary
View:
Show?
Quarter Result
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
Revenue 179,300 189,400 93,200 215,400 200,900 200,500 186,500 -0.65%
PBT -17,900 -3,800 -58,500 -7,700 16,100 18,800 37,300 -
Tax -3,800 900 -3,000 -3,400 3,000 6,100 13,900 -
NP -14,100 -4,700 -55,400 -4,200 13,100 12,900 23,400 -
Tax Rate - - - - -18.63% -32.45% -37.27% -
Total Cost 193,400 194,100 148,600 219,600 187,800 187,600 163,100 2.87%
Ratio Analysis
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
NP Margin -7.86 -2.48 -59.44 -1.95 6.52 6.43 12.55 -
Per Share
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
EPS -0.18 -0.06 -0.74 -0.06 0.19 0.19 0.33 -
EPS Diluted -0.18 -0.06 -0.74 -0.06 0.18 0.19 0.32 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.